Why Your Digital Strategy May Be Incomplete: How Legacy Models Prevent End-To-End Digital Manufacturing

  • Why pharma organizations must diversify their digitization strategy, looking beyond legacy models that prevent complete, end-to-end digital manufacturing
  • How a light, configurable MES can remove paper from production entirely and enable any-sized pharma company to fully utilize their MES across all lines and sites
  • How a modern MES can digitally connect different data sources to close offline data gaps, improve data integrity and visibility, and unlock critical business intelligence

Marty Smyth
SVP, Go-To-Market Strategy

As the senior vice president of go-to-market strategy, Marty Smyth is responsible market intelligence, product strategy, and bringing MasterControl quality and manufacturing products to market globally. He brings 20 years of technology strategy, marketing, sales, and support experience across high-growth private SaaS companies as well as Fortune 500 companies.

In previous roles, Marty has driven strategic planning, customer experience, and go-to-market for technology leaders like Cisco, Panasonic, Verizon, and AT&T. He is a University of Notre Dame alumnus.

MasterControl Inc. is the leading provider of cloud-based quality and compliance software for life sciences and other regulated industries. Our mission is to help our customers to bring life-changing products to more people sooner.

Use the MasterControl Manufacturing Excellence™ solution to digitize and automate manufacturing data to help you reduce errors and accelerate product release times – thereby delivering immediate, measurable value to your business.

Join over 1,000 companies worldwide that use our solutions to achieve new levels of excellence across product development, clinical trials, regulatory affairs, quality management, supply chain, manufacturing and postmarket surveillance. Learn more at www.mastercontrol.com.